Peter Coombs is a Principal Scientist at LifeArc in the Target Delivery Group. Following completion of his PhD in Biochemistry at the University of Oxford, he took a post-doctoral position at the National Institute for Medical Research looking at structural and biophysical properties of influenza viruses. Since 2012, he has worked at LifeArc, predominantly using biophysical approaches to further small molecule and antibody drug discovery projects, with a particular focus on fragment screening.
Monday, January 27
4:00 PM – 4:30 PM